These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response. Hodgins B; Yam KK; Winter K; Pillet S; Landry N; Ward BJ Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021303 [TBL] [Abstract][Full Text] [Related]
4. [Protective properties of candidate genetically engineered vaccines against avian influenza viruses constructed on the basis of recombinant adenoviral vectors]. Sedova ES; Shmarov MM; Tutykhina IL; Barykova IuA; Verkhovskaia LV; Logunov DIu; Naroditskiĭ BS; Gintsburg AL Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):44-8. PubMed ID: 20734718 [TBL] [Abstract][Full Text] [Related]
5. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine. Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
7. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge. Galarza JM; Latham T; Cupo A Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948 [TBL] [Abstract][Full Text] [Related]
8. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants. Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604 [TBL] [Abstract][Full Text] [Related]
9. Intramuscular and intranasal immunization with an H7N9 influenza virus-like particle vaccine protects mice against lethal influenza virus challenge. Ren Z; Zhao Y; Liu J; Ji X; Meng L; Wang T; Sun W; Zhang K; Sang X; Yu Z; Li Y; Feng N; Wang H; Yang S; Yang Z; Ma Y; Gao Y; Xia X Int Immunopharmacol; 2018 May; 58():109-116. PubMed ID: 29571081 [TBL] [Abstract][Full Text] [Related]
10. Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge. Zheng X; Oduro JD; Boehme JD; Borkner L; Ebensen T; Heise U; Gereke M; Pils MC; Krmpotic A; Guzmán CA; Bruder D; Čičin-Šain L PLoS Pathog; 2019 Sep; 15(9):e1008036. PubMed ID: 31525249 [TBL] [Abstract][Full Text] [Related]
11. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. Major D; Chichester JA; Pathirana RD; Guilfoyle K; Shoji Y; Guzman CA; Yusibov V; Cox RJ Hum Vaccin Immunother; 2015; 11(5):1235-43. PubMed ID: 25714901 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice. Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721 [TBL] [Abstract][Full Text] [Related]
13. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745 [TBL] [Abstract][Full Text] [Related]
14. Orally administered live attenuated Salmonella Typhimurium protects mice against lethal infection with H1N1 influenza virus. Kamble NM; Hajam IA; Lee JH Vet Microbiol; 2017 Mar; 201():1-6. PubMed ID: 28284594 [TBL] [Abstract][Full Text] [Related]
15. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. Gao W; Soloff AC; Lu X; Montecalvo A; Nguyen DC; Matsuoka Y; Robbins PD; Swayne DE; Donis RO; Katz JM; Barratt-Boyes SM; Gambotto A J Virol; 2006 Feb; 80(4):1959-64. PubMed ID: 16439551 [TBL] [Abstract][Full Text] [Related]
16. Baculovirus-produced influenza virus-like particles in mammalian cells protect mice from lethal influenza challenge. Tang XC; Lu HR; Ross TM Viral Immunol; 2011 Aug; 24(4):311-9. PubMed ID: 21830902 [TBL] [Abstract][Full Text] [Related]
18. Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. Tompkins SM; Lin Y; Leser GP; Kramer KA; Haas DL; Howerth EW; Xu J; Kennett MJ; Durbin RK; Durbin JE; Tripp R; Lamb RA; He B Virology; 2007 May; 362(1):139-50. PubMed ID: 17254623 [TBL] [Abstract][Full Text] [Related]
19. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens. Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655 [TBL] [Abstract][Full Text] [Related]
20. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]